Depomed, Dendreon lead drug stocks higher
August 04, 2010 at 10:40 AM EDT
Investors bid up Depomed shares on news that Pfizer won't file a lawsuit to prevent the launch of Depomed's version of a Pfizer painkiller.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.